|
NCOA6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53969999999926E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.144400E-03 |
| Normal-vs-Stage2 |
8.918900E-03 |
| Normal-vs-Stage3 |
3.52110000045869E-07 |
| Normal-vs-Stage4 |
2.23019999999741E-05 |
| Stage1-vs-Stage2 |
4.542000E-01 |
| Stage1-vs-Stage3 |
5.429500E-04 |
| Stage1-vs-Stage4 |
1.112180E-02 |
| Stage2-vs-Stage3 |
1.014630E-01 |
| Stage2-vs-Stage4 |
2.387600E-01 |
| Stage3-vs-Stage4 |
6.659600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68339999999856E-05 |
| Normal-vs-AfricanAmerican |
9.210300E-04 |
| Normal-vs-Asian |
7.264000E-01 |
| Caucasian-vs-AfricanAmerican |
4.899000E-01 |
| Caucasian-vs-Asian |
6.009600E-02 |
| AfricanAmerican-vs-Asian |
5.558500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11449999999447E-05 |
| Normal-vs-Female |
8.774700E-04 |
| Male-vs-Female |
1.847020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.828430E-02 |
| Normal-vs-Age(41-60Yrs) |
3.662600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.0026999999766E-06 |
| Normal-vs-Age(81-100Yrs) |
1.225520E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.961000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.838600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.250420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.926500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.350390E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.888100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.614400E-01 |
| Normal-vs-Grade 2 |
1.582050E-03 |
| Normal-vs-Grade 3 |
2.99900000000353E-06 |
| Normal-vs-Grade 4 |
2.15459999999279E-05 |
| Grade 1-vs-Grade 2 |
1.769800E-02 |
| Grade 1-vs-Grade 3 |
1.715420E-03 |
| Grade 1-vs-Grade 4 |
9.624300E-04 |
| Grade 2-vs-Grade 3 |
4.742200E-02 |
| Grade 2-vs-Grade 4 |
3.229600E-02 |
| Grade 3-vs-Grade 4 |
4.672600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.104900E-03 |
| Normal-vs-ccB subtype |
7.571800E-04 |
| ccA subtype-vs-ccB subtype |
2.174600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.359500E-04 |
| Normal-vs-N1 |
8.470400E-02 |
| N0-vs-N1 |
9.674000E-01 |
|
|
